home / stock / atxi / atxi quote
Last: | $0.1311 |
---|---|
Change Percent: | -2.96% |
Open: | $0.1351 |
Close: | $0.1351 |
High: | $0.1373 |
Low: | $0.131 |
Volume: | 280,744 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1311 | $0.1351 | $0.1351 | $0.1373 | $0.131 | 280,744 | 04-18-2024 |
$0.1351 | $0.132 | $0.1351 | $0.139 | $0.1293 | 810,701 | 04-17-2024 |
$0.1315 | $0.1241 | $0.1315 | $0.135 | $0.1224 | 428,505 | 04-16-2024 |
$0.125 | $0.139 | $0.125 | $0.14 | $0.1152 | 2,318,681 | 04-15-2024 |
$0.1355 | $0.1441 | $0.1355 | $0.1446 | $0.1352 | 267,339 | 04-12-2024 |
$0.1412 | $0.1496 | $0.1412 | $0.155 | $0.1351 | 1,223,864 | 04-11-2024 |
$0.1496 | $0.15 | $0.1496 | $0.151 | $0.1455 | 302,355 | 04-10-2024 |
$0.1469 | $0.1522 | $0.1469 | $0.1522 | $0.1456 | 819,634 | 04-09-2024 |
$0.1535 | $0.15 | $0.1535 | $0.1548 | $0.143 | 1,128,654 | 04-08-2024 |
$0.1488 | $0.143 | $0.1488 | $0.15 | $0.1418 | 626,255 | 04-05-2024 |
$0.147 | $0.145 | $0.147 | $0.155 | $0.142 | 318,552 | 04-04-2024 |
$0.149 | $0.1543 | $0.149 | $0.158 | $0.1441 | 743,023 | 04-03-2024 |
$0.15 | $0.15 | $0.15 | $0.1502 | $0.142 | 717,903 | 04-02-2024 |
$0.1501 | $0.154 | $0.1501 | $0.156 | $0.146 | 647,991 | 04-01-2024 |
$0.1475 | $0.1495 | $0.1475 | $0.1585 | $0.1456 | 799,429 | 03-29-2024 |
$0.1475 | $0.1495 | $0.1475 | $0.1585 | $0.1456 | 799,429 | 03-28-2024 |
$0.1526 | $0.1554 | $0.1526 | $0.1554 | $0.1482 | 495,501 | 03-27-2024 |
$0.151 | $0.155 | $0.151 | $0.1561 | $0.1454 | 1,145,146 | 03-26-2024 |
$0.155 | $0.149 | $0.155 | $0.16 | $0.14 | 2,770,774 | 03-25-2024 |
$0.1512 | $0.1475 | $0.1512 | $0.1575 | $0.1475 | 1,584,613 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ:ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical compan...
MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced th...